Analysis of new drugs whose clinical development and regulatory approval were hampered during their introduction in Japan
京都大学 === 0048 === 新制・論文博士 === 博士(医学) === 乙第12801号 === 論医博第2073号 === 新制||医||1001(附属図書館) === 80845 === 京都大学大学院薬学研究科創薬科学専攻 === (主査)教授 川上 浩司, 教授 松原 和夫, 教授 今中 雄一 === 学位規則第4条第2項該当 === Doctor of Medical Science === Kyoto University === DFAM...
Main Author: | Asada, Ryuta |
---|---|
Other Authors: | 川上, 浩司 |
Format: | Doctoral Thesis |
Language: | English |
Published: |
Kyoto University
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/2433/185190 |
Similar Items
-
Problems of clinical trials of new drugs as a basis of modern evidence-based medicine
by: V S Moiseev, et al.
Published: (2008-12-01) -
The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs
by: Aviv Ladanie, et al.
Published: (2018-09-01) -
Regulation and status of herbal medicine clinical trials in Korea
by: Boram Lee, et al.
Published: (2021-06-01) -
Trend of clinical drug trials in type 2 diabetes mellitus over last decade
by: Rakesh Parikh, et al.
Published: (2011-01-01) -
A two-year evaluation of the minutes of Investigational New Drug committee meetings
by: Jeffrey Pradeep Raj, et al.
Published: (2021-01-01)